Showing results (31-40 of 204) with videos related to
Sort By:
Pageof 21
British Journal of Haematology|June 9, 2006
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Julie Teruya-Feldstein, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphomaIrene A Burger, Hebert Alberto Vargas, Debra A Goldman, et al.Clinical Lymphoma, Myeloma & Leukemia|October 31, 2012
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceMartin H Voss, Matthew A Lunning, Jocelyn C Maragulia, et al.Leukemia & Lymphoma|August 27, 2016
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practiceIda Wong-Sefidan, Michelle Byrtek, Xiaolei Zhou, et al.Blood|August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseDavid J Straus, Carol S Portlock, Jing Qin, et al.Cancer|October 13, 2007
Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphomaFabio M Iwamoto, Jazmin Schwartz, Neeta Pandit-Taskar, et al.Cancers|January 28, 2026
Romiplostim for Prevention of Severe Chemotherapy-Induced Thrombocytopenia in Lymphoma Patients-Phase I StudyErel Joffe, Zachary Epstein-Peterson, Lorenzo Falchi, et al.Genes, Chromosomes & Cancer|October 16, 2002
Molecular cytogenetic analysis of genomic instability at the 1q12-22 chromosomal site in B-cell non-Hodgkin lymphomaTakahiro Itoyama, Gouri Nanjungud, Weiyi Chen, et al.Leukemia & Lymphoma|July 16, 2005
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacyJeffrey L Halaas, Craig H Moskowitz, Steven Horwitz, et al.Cancer Journal (Sudbury, Mass.)|November 6, 2002
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantationDorothy Pan, Craig H Moskowitz, Andrew D Zelenetz, et al.Pageof 21